Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Clinical Efficacy and Safety Evaluation of HCP1904-2 in Essential Hypertension Patients [Phase 3]
Phase 3 clinical trial assessing the efficacy and safety of HCP1904-2 in patients with essential hypertension has been completed.
-
CLINICAL_TRIALS trial_result · 2023-09-21Clinical Trial Update: Chronic Sleep Deprivation Among the Poor: A Lab-in-the-field Approach [NA]
Completed clinical trial investigating chronic sleep deprivation effects on blood pressure and depression; results posted.
-
FDA approval · 2023-09-20FDA Approved: NEBIVOLOL — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nebivolol from Aurobindo Pharma Limited. This action confirms the approval of an updated generic…
-
FDA approval · 2023-09-20FDA Approved: NEBIVOLOL — Supplemental Application (AvKARE)
FDA approved a supplemental application for Nebivolol hydrochloride (Nebivolol) manufactured by AvKARE.
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: SPYRAL HTN-ON MED Study of Renal Denervation With the Symplicity Spyral™ Multi-electrode Renal Denervation System [NA]
This update reports completion of the SPYRAL HTN-ON MED study evaluating Medtronic's Symplicity Spyral multi-electrode renal denervation sys…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Validation of Noninvasive Blood Pressure Device [NA]
Clinical trial update on validation of a noninvasive blood pressure device; study completed with results posted in 2023.
-
FDA approval · 2023-09-12FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for Telmisartan and Hydrochlorothiazide from Alembic Pharmaceuticals Limited.
-
FDA approval · 2023-09-12FDA Approved: METOPROLOL SUCCINATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for metoprolol succinate from Mylan Pharmaceuticals Inc.
-
FDA approval · 2023-09-11FDA Approved: LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE — Supplemental Application (NorthStar Rx LLC)
FDA approved a supplemental application for the generic fixed-dose combination losartan potassium and hydrochlorothiazide from NorthStar Rx …
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Atenas Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial of Atenas Association for Type II diabetes mellitus and hypertension was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2023-09-08Clinical Trial Update: Efficacy and Safety of Egito Association in the Treatment of Type II Diabetes Mellitus and Hypertension [Phase 3]
Phase 3 clinical trial investigating Egito Association for Type II diabetes mellitus and hypertension has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2023-09-08Clinical Trial Update: Norepinephrine Prevent Post-induction Hypotension in High-risk Patients [Phase 4]
Phase 4 trial update exploring norepinephrine to prevent post-induction hypotension in high-risk surgical patients.
-
FDA approval · 2023-09-05FDA Approved: SPIRONOLACTONE — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original ANDA for spironolactone from Amneal Pharmaceuticals NY LLC, enabling a generic version of the diuretic.
-
FDA approval · 2023-08-25FDA Approved: IRBESARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for the generic fixed-dose combination IRBESARTAN AND HYDROCHLOROTHIAZIDE from Alembic Pharmaceutica…
-
FDA approval · 2023-08-25FDA Approved: NEBIVOLOL — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approves ANI Pharmaceuticals' supplemental application for Nebivolol, enabling a generic nebivolol product.
-
FDA approval · 2023-08-25FDA Approved: NEBIVOLOL — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for Nebivolol from Ascend Laboratories, LLC, indicating an updated regulatory approval for the drug.
-
FDA approval · 2023-08-25FDA Approved: TELMISARTAN AND HYDROCHLOROTHIAZIDE — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved Aurobindo Pharma Limited's supplemental application for a generic telmisartan/hydrochlorothiazide combination tablet.
-
FDA approval · 2023-08-24FDA Approved: SPIRONOLACTONE — Supplemental Application (Padagis US LLC)
FDA approved a supplemental application for spironolactone from Padagis US LLC, indicating an updated regulatory action on this product (sup…
-
FDA approval · 2023-08-23FDA Approved: NEBIVOLOL — Supplemental Application (Lifestar Pharma LLC)
The FDA approved a supplemental application for Nebivolol submitted by Lifestar Pharma LLC.
-
FDA approval · 2023-08-23FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Micro Labs Limited)
FDA approved a supplemental application for losartan potassium from Micro Labs Limited under an ANDA, indicating an update to the drug's app…
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Trial of AD113 and Atomoxetine in OSA Patients With Hypertension [Phase 2]
Phase 2 trial of AD113 and atomoxetine in obstructive sleep apnea patients with hypertension has completed.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Text My Hypertension BP Meds NOLA [NA]
A completed clinical trial investigating hypertension medications sponsored by Tulane University; results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-08-21Clinical Trial Update: Effect of Renin-angiotensin-system Blockade on Urinary Free Light Chains in Patients With Type 2 Diabetes Mellitus [Phase 4]
Phase 4 trial update evaluating the impact of renin-angiotensin-system blockade on urinary free light chains in patients with type 2 diabete…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension [Phase 4]
Phase 4 clinical trial evaluating the effect of fimasartan on extended RAS and vascular functions in patients with type 2 diabetes and hyper…
-
CLINICAL_TRIALS trial_result · 2023-08-14Clinical Trial Update: Spironolactone in CKD Enabled by Chlorthalidone: PILOT [Phase 2]
A Phase 2 trial update for Spironolactone in chronic kidney disease enabled by chlorthalidone (PILOT).